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ABSTRACT
Objective: To externally validate and extend a recently
proposed prediction model to diagnose obstructive
coronary artery disease (CAD), with the ultimate aim to
better select patients for coronary angiography.
Design: Analysis of individual baseline data of a
prospective cardiology cohort.
Setting: Single-centre secondary and tertiary
cardiology clinic.
Participants: 4888 patients with suspected CAD,
without known previous CAD or other heart diseases,
who underwent an elective coronary angiography
between 2004 and 2008 as part of the prospective
Coronary Artery disease Risk Determination In
Innsbruck by diaGnostic ANgiography (CARDIIGAN)
cohort. Relevant data were recorded as in routine
clinical practice.
Main outcome measures: The probability of
obstructive CAD, defined as a stenosis of minimally
50% diameter in at least one of the main coronary
arteries, estimated with the predictors age, sex, type of
chest pain, diabetes status, hypertension,
dyslipidaemia, smoking status and laboratory data.
Missing predictor data were multiply imputed.
Performance of the suggested models was evaluated
according to discrimination (area under the receiver
operating characteristic curve, depicted by the c
statistic) and calibration. Logistic regression modelling
was applied for model updating.
Results: Among the 4888 participants (38% women
and 62% men), 2127 (44%) had an obstructive CAD.
The previously proposed model had a c statistic of
0.69 (95% CI 0.67 to 0.70), which was lower than
the expected c statistic while correcting for case
mix (c=0.80). Regarding calibration, there was
overprediction of risk for high-risk patients.
All logistic regression coefficients were smaller than
expected, especially for the predictor ‘chest pain’.
Extension of the model with high-density lipoprotein
and low-density lipoprotein cholesterol, fibrinogen,
and C reactive protein led to better discrimination
(c=0.72, 95% CI 0.71 to 0.74, p<0.001 for
improvement).
Conclusions: The proposed prediction model has
a moderate performance to diagnose obstructive
CAD in an unselected patient group with suspected
CAD referred for elective CA. A small, but significant
improvement was attained by including easily
available and measurable cardiovascular risk factors.
Strengths and limitations of this study
▪ In our study of obstructive coronary artery
disease diagnostics in a large cohort, we could
analyse prospectively collected, good-quality
data including various routine laboratory
measurements.
▪ The results reflect those of patients in daily clin-
ical routine where one has to evaluate the avail-
able information for the diagnostic work-up, a
situation in which a prediction model can be an
aid to make the best possible decisions.
▪ Not all information was complete, but multiple
imputations counteracted this deficiency.
▪ An effect of verification bias cannot be ruled out
and more elaborate evaluation of chest pain
symptoms might be advantageous.
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INTRODUCTION
Since conventional coronary angiography (CA) is expen-
sive and has a small, but not negligible risk of complica-
tion, prior diagnostic testing is recommended, especially
in patients with an intermediate pretest probability of
obstructive coronary artery disease (CAD). However, the
use of multiple non-invasive tests in an individual patient
is common which again might be costly and not free of
risk (because of radiation and exposure to contrast
medium). In this context, Diamond and Forrester1 pre-
sented the now widely known risk prediction model
about 35 years ago, which was followed by efforts to
expand it for an even better diagnostic work-up.2
Genders et al3 proposed an update and extension using
recent data of a consortium from predominantly
European countries.
Although being solely a ‘luminography’, invasive CA is
still the reference standard to diagnose an obstructive
CAD. Given the limitations of available clinical predic-
tion models and non-invasive tests, a high proportion of
CA in daily practice reveal no obstructive CAD or even
no CAD at all and, hence, offer no improvement in
patient management in terms of subsequent revasculari-
sation for symptom relief or prognosis. For example, in
about 43% of the cases in a study of 18 hospitals involv-
ing 2062 patients, an obstructive CAD was excluded.3 If
a CA could be more precisely restricted to those patients
with obstructive CAD (by use of a thorough cardiovascu-
lar evaluation including laboratory measures and a
careful clinical assessment, summarised in a prediction
model), the potential beneﬁts of avoiding unnecessary
invasiveness, non-invasive testing, costs, inconvenience to
the patients and probably anxiety are obvious.
We can estimate the probability of obstructive CAD for
adult patients with a diagnostic model based on age, sex
and type of chest pain (the Diamond and Forrester
model,1 labelled ‘basic model’ by Genders et al3). A con-
temporary and more extensive clinical model also con-
sidered traditional cardiovascular risk factors like
diabetes, hypertension, dyslipidaemia and smoking
status.3 Here, we aim to validate this proposed model in
an unselected cohort of patients with suspected CAD
referred for elective invasive CA and to test the incre-
mental predictive value of an extension with standard
laboratory parameters.
MATERIALS AND METHODS
Patients
Between February 2004 and April 2008, 8296 consecu-
tive patients, referred for elective CA to invasively evalu-
ate the prevalence and severity of obstructive CAD, were
included in the Coronary Artery disease Risk
Determination In Innsbruck by diaGnostic ANgiography
(CARDIIGAN) cohort. Patients were 18 years of age or
older with chest pain or symptoms suggestive of CAD
(predominantly dyspnoea) and/or non-invasive evi-
dence of CAD referred for elective CA. Patients were
excluded when undergoing (1) an elective CA before or
after heart transplantation, (2) an elective CA prior to
solid organ transplantation, (3) an elective CA before
heart valve repair or replacement, or with valvular heart
disease as leading clinical diagnosis, (4) an isolated right
heart catheterisation, (5) an electrophysiological proced-
ure (pace-maker implantation or catheter ablation) as
leading clinical indication, (6) an elective CA because of
a known or suspected congenital heart disease as
leading clinical diagnosis (eg, atrial septal defect, ven-
tricular septal defect or patent foramen ovale), or (7)
when referred for other reasons (like myocardial biopsy,
aortic aneurysms, myxoma, endocarditis or prior failed
angiography). Patients referred for an acute non-elective
CA in the setting of acute coronary syndrome (ie, for a
primary or rescue percutaneous coronary intervention
(PCI) for ST elevation myocardial infarction or as an
early invasive strategy for non-ST elevation myocardial
infarction) had not been recorded in CARDIIGAN, but
participated in the Austrian Acute-PCI registry. Also,
those with a history of myocardial infarction, either
recent (within 6 months) or prior (more than 6 months
ago), were excluded as they have known CAD. Overall,
there were 5606 patients included (68%) (with 5929
visits) and of these 4888 (87%) were ﬁrst-time patients
(without a history of coronary revascularisation, ie, PCI
or coronary artery bypass grafting) available for the
current study.
The data were primarily gathered in a prospective
quality enhancement initiative with cardiovascular risk
factor assessment, but in the normal daily routine, and
extended with a retrospective patient record extraction.
The hospital is a local secondary facility and also has a
larger regional, tertiary function with specialised aca-
demic healthcare. The patients were asked for their
written informed consent for the CA on a routine basis.4
The ﬁrst author had access to all data in the study and is
responsible for its processing.
Data
Information was recorded on basic characteristics of the
patients, medical history, symptoms (present or absent),
laboratory results and therapy decision immediately in
the catheterisation laboratory. Concerning symptoms,
patients were subdivided into unstable, stable and those
without any symptoms of angina pectoris; in the current
analysis those with unstable and stable symptoms were
merged together with those with chest pain. The differ-
entiation of the two types of angina is theoretically clear,
but generally not in clinical practice where symptom
description and allocation vary intraindividually and
interindividually. The ‘unstable’ category was rather
small (16% of patients). A sensitivity analysis was per-
formed later to investigate the effect of other classiﬁca-
tions of the predictor or of leaving out the unstable chest
pain patients; the results were very similar. Past myocar-
dial infarctions, prior PCI and prior bypass grafting were
assessed, as well as family history of myocardial infarction
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(male ﬁrst-degree relatives below 55 years and female
ﬁrst-degree relatives below 65 years), hypertension
(including treatment), diabetes mellitus (including treat-
ment),5 known cardiomyopathy and rhythm on baseline
ECG. Also, baseline levels of total cholesterol, high-
density lipoprotein (HDL) cholesterol, low-density lipo-
protein (LDL) cholesterol, triglycerides, ﬁbrinogen,
C reactive protein, thrombocytes, haemoglobin, urea,
creatinine, γ-glutamyltransferase (measured at 37°C),
calcium, phosphate and uric acid were recorded. In add-
ition, prothrombin time was measured and the glomeru-
lar ﬁltration rate estimated according to the Modiﬁcation
of Diet in Renal Disease 2 (MDRD2) formula:6
estimated glomerular ﬁltration rate=186×creatini-
ne(−1.154)×age(−0.203)×(0.742 if woman)
In the multivariable analyses, triglycerides, ﬁbrinogen
and γ-glutamyltransferase were log-transformed because
of skewed distributions. C reactive protein was dichoto-
mised into ≤1.00 vs >1.00 mg/dL. Dyslipidaemia was
deﬁned as total cholesterol ≥200 mg/dL or treatment
with lipid-lowering drugs.3
CA was performed by using standard Judkins tech-
nique, predominantly via a right femoral access. We
used the routine ad hoc judgements of the treating
interventional cardiologists, who all had ample experi-
ence in interpreting CAD by angiography, reﬂecting a
real-life setting. Despite known limitations, visual estima-
tion was applied to deﬁne obstructive CAD, instead of
using quantitative coronary angiographic techniques or
even pressure wire measurements, as it is the most com-
monly used method in clinical routine. The following
segments of the coronary tree were separately evaluated
and categorised by visual estimation of lumen diameter
reduction into 0%, 1–49%, 50–69% and ≥70%: left
main stem, left anterior descending artery (proximal
and non-proximal separately), circumﬂex artery includ-
ing relevant marginal branches (>2 mm diameter), diag-
onal branches (>2 mm diameter) and right coronary
artery. Prior coronary interventions were recorded as
plain old balloon angioplasty or stent implantation,
graded as a signiﬁcant restenosis absent or present.
When dichotomising CAD in the main analysis as
obstructive or not, the cut-off was set at 50% stenosis.
Otherwise, the cut-off was 70%, and the left main artery
counted as three vessels (where ≥50% stenosis was reset
to ≥70%) and the three categories of the left anterior
descending arteries counted as one.7 8
Statistical analysis
Patient characteristics are presented as proportions for
categorical and by means and SDs (or medians and
IQR) for continuous variables. Overall, 1.7% of the clin-
ical data were missing, in contrast to the medication
information with about 46% missing in seven variables
(concerning 60% of the patients). Since the missing
clinical data were not conﬁned to a particular group of
participants, in total ∼28% of them had one or more
missing values. To avoid possible biases, we imputed the
failing information numerous times using all available
information9 after an extensive exploration of the miss-
ingness.10 The multiple imputations involved a total of
20 imputations, with application of the Markov Chain
Monte Carlo technique.11
Multivariable logistic regression modelling was applied
to update the CAD prediction model proposed by
Genders et al.3 12 Since our cardiology department pro-
vides healthcare for a rather wide range of patients, the
characteristics of the present cohort might differ to those
of the development model. Therefore, a ‘case mix cor-
rected c statistic’13 was estimated as a benchmark value, as
well as the c statistic when reﬁtting the regression model
to the current data.14 The model updating included an
extension with additional predictors, evaluated through
likelihood ratio tests of the model extensions in a forward
stepwise manner, each time considering the predictor
with the strongest difference ﬁrst.12
For assessment of the performance of a prediction
model, discriminative ability and calibration are essen-
tial.15 Discrimination is the degree to which a prediction
model distinguishes between patients with an outcome
(signiﬁcant stenosis) and those without. Calibration cap-
tures the correspondence between the observed out-
comes (diagnosis of obstructive CAD) and the
predictions.12 As the measure for discrimination, the
area under the receiver operating characteristic curve is
commonly used; in a situation with a binary outcome, as
in this case, this is the same as the concordance (c) stat-
istic used in generalised linear regression models. To
evaluate the agreement of observed outcomes and pre-
dictions, calibration-in-the-large and the calibration
slope are examined together with the calibration plot.16
This graph depicts the ascending prediction probability
of CAD, commonly divided into 10 equal groups, set off
against the corresponding actually observed relative fre-
quency. Here, we estimated a ﬂexible, non-linear, cali-
bration curve with a 95% band of conﬁdence.17
Additionally, we conducted a decision curve analysis to
assess the clinical consequence of the models in com-
parison with a default approach of angiography for all
included patients.18
The cut-off value for statistical signiﬁcance was set at a
two-sided p value of 0.05. The data preparation was
performed with SPSS V.19.0, and the analyses with
Stata/MP V.11.2 (14.1 for the decision curve analysis)
and R V.3.1 software.
RESULTS
Overall, 2127 of the 4888 (44%) patients had obstructive
CAD as diagnosed by invasive CA. Patients with stenosis
were predominantly men, older and more often
reported chest pain, compared with those without an
obstructive CAD diagnosis. Furthermore, the risk factor
burden was higher among these patients (table 1).
When differentiating obstructive CAD by its severity,
the same univariate predictors showed a trend across the
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categories of no CAD, non-obstructive CAD, and one-
vessel, two-vessel and three-vessel disease (table 2). For
example, in the case of HDL cholesterol the mean level
in the ﬁrst category was 61 mg/dL and was lower in
every next one, with 52 mg/dL among the two-vessel
and three-vessel disease patients. The other predictors
generally showed higher values with more severe CAD.
The c statistic for the previously proposed model was
0.69 (95% CI 0.67 to 0.70); at derivation the model had
attained c=0.79.3 Based on the case mix, the expected
discriminative ability was even higher than at develop-
ment (c=0.80). Calibration was poor (ﬁgure 1A). The
predictions encompassed practically the whole range
from 0% to 100%, whereas the observed proportion of
obstructive CAD cases was between 5% and 75%.
Recalibration analysis showed a new intercept of −1.04
(95% CI −1.10 to −0.97; reﬂecting the lower observed
than expected prevalence) and a calibration slope of
0.63 (95% CI 0.58 to 0.69; reﬂecting overall smaller than
expected effects of the diagnostic characteristics).
Additionally, the separate predictors were tested for
model updating; sex and chest pain gave signiﬁcant
results (difference in coefﬁcients 0.42 (p<0.001) and
−0.42 (p<0.001), respectively). With complete
re-estimation, all the new coefﬁcients were considerably
smaller than the original estimates, except for dyslipidae-
mia (see online supplementary table, re-estimated
model). The discrimination of this re-estimated model
was slightly higher than when applying the original
model (c=0.70, 95% CI 0.68 to 0.71). The range of pre-
dictions is shrunk, with the maximum at about 85%
(ﬁgure 1B).
Extending the model to include the laboratory results,
HDL and LDL cholesterol, ﬁbrinogen, and C reactive
protein contributed exceedingly to the recalibrated
model next to chest pain, hypertension and smoking
(each p<0.02). The discrimination increased to c=0.72
(95% CI 0.71 to 0.74). The fully updated model (see
online supplementary table, extended model) showed
smaller coefﬁcients than the previously proposed model
for age, chest pain, diabetes, hypertension and smoking,
and the interaction of chest pain and diabetes was negli-
gible. The laboratory predictors had small coefﬁcient
values (comparison of the 75 vs 25 centiles: HDL choles-
terol OR=0.67, LDL cholesterol OR=1.28, ﬁbrinogen
OR=1.27 and C reactive protein raised vs low OR=1.27).
With a cut-off at 50% estimated probability of a sten-
osis, the improvement in speciﬁcity of the extended
Table 1 Baseline characteristics of the study patients by 50% stenosis status
No CAD Obstructive CAD
p Value
Total
N missing
Genders*
n=2761 (56%) n=2127 (44%) n=4888 n=1251
Sex (male) 53% 74% <0.001 62% 0 70%
Age (years), ms 63 (11) 66 (10) <0.001 64 (11) 0 64 (10)
Age (years), range 18 to 89 26 to 87 18 to 89 0 18 to 93
Chest pain 56% 68% <0.001 61% 0 53%
Diabetes mellitus 13% 19% <0.001 15% 0 18%
Hypertension 73% 80% <0.001 76% 0 67%
Ever smoking 43% 49% <0.001 46% 640 36%
Body mass index (kg/m2), ms 27.1 (4.5) 27.0 (4.0) 0.54 27.0 (4.3) 60 28 (NA)
Family history of myocardial
infarction
22% 21% 0.75 22% 0
Total cholesterol (mg/dL), ms 199 (44) 200 (45) 0.23 199 (44) 257
HDL cholesterol (mg/dL), ms 59 (18) 53 (15) <0.001 56.6 (17.2) 312
LDL cholesterol (mg/dlL), ms 126 (36) 131 (39) <0.001 128 (37) 310
Triglycerides (mg/dL), mi 120 (87; 166) 130 (96; 181) <0.001 125 (90; 173) 263
Fibrinogen (mg/dL), mi 352 (285; 424) 370 (305; 460) <0.001 360 (293; 441) 119
C reactive protein >1.00 mg/dL 11% 17% <0.001 14% 96
Prothrombin time (%), ms 103 (13) 104 (12) 0.07 104 (13) 76
Thrombocytes (×1000 U/µL), ms 236 (62) 232 (68) 0.08 234 (64) 79
Haemoglobin (g/dL), ms 14.3 (1.5) 14.4 (1.5) 0.02 14.4 (1.5) 60
Creatinine (mg/dL), ms 0.98 (0.46) 1.07 (0.59) <0.001 1.02 (0.52) 53
eGFR (mL/min/1.73 m2), ms 78.2 (20.0) 76.0 (20.5) <0.001 77.2 (20.2) 53
γ-glutamyltransferase (U/L), mi 30 (19; 50) 33 (22; 54) <0.001 31 (20; 51) 165
Uric acid (mg/dL), ms 6.12 (1.71) 6.49 (1.67) <0.001 6.28 (1.71) 428
Urea (mg/dL), mi 34.1 (28.3; 41.9) 36.4 (29.9; 44.4) <0.001 35.0 (28.9; 43.0) 128
Coronary artery disease 0
Non-obstructive 100% 0% 56% 40%
Moderate (50–70%) 0% 11% 5% 45%
Severe (≥70% or LM≥50%) 0% 89% 39% 16%
*Comparable data from the hospitals with a high prevalence setting of the study by Genders et al.3
CAD, coronary artery disease; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LM,
left main artery; mi, median (IQR); ms, mean (SD); NA, SD not available.
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model, in comparison to the re-estimated one, was mod-
erate increasing from 74.5% (95% CI 72.9% to 76.1%)
to 76.0% (95% CI 74.3% to 77.5%). Sensitivity however
gained in the new model, from 52.3% (95% CI 50.2% to
54.4%) to 55.7% (95% CI 53.6% to 57.8%). From the
decision curve analysis, it appeared that the extended
model had an extra net beneﬁt in the range of thresh-
old probability between about 20% and 70% (ﬁgure 2),
being larger than when subjecting none or contrarily all
patients to angiography. Threshold probability (ie, the
probability above which it is chosen to perform angiog-
raphy) can vary according to patient preference and
depends on appraisal by the physician. When set at
30%, sensitivity is 0.88, speciﬁcity 0.40 and the extra net
beneﬁt due to the model 0.04; at 40%, these measures
are 0.74, 0.58 and 0.11, respectively. Per 100 patients
about 10 and 16 angiographies, respectively, can thus be
saved.
DISCUSSION
Validation of the Genders et al3 model in the
CARDIIGAN cohort showed a lower discriminative
ability and poor calibration of risk predictions. We con-
ﬁrmed that the previously suggested predictors were
associated with the presence of an obstructive CAD, but
effects were weaker at validation than at development.
We also found consistent results according to severity of
obstructive CAD. An improvement in discrimination was
obtained by optimising the model ﬁt to the CARDIIGAN
data and by extension with four laboratory risk factors
(c from 0.69 to 0.72).
In practice, the updated and extended model predicts
a probability of CAD diagnosis of only 5% in a non-
smoking female patient aged 40 years with diabetes
(no chest pain, no hypertension and no dyslipidaemia),
HDL cholesterol of 66 mg/dL, LDL cholesterol of
103 mg/dL, ﬁbrinogen of 293 mg/dL and C reactive
protein of 0.11 mg/dL. Conversely, it predicts a probabil-
ity of obstructive CAD as high as 72% in a man of
75 years of age who smokes, has chest pain and hyperten-
sion (but neither diabetes nor dyslipidaemia), HDL chol-
esterol of 44 mg/dL, LDL cholesterol of 152 mg/dL,
ﬁbrinogen of 440 mg/dL and C reactive protein of
0.55 mg/dL. Clearly, this information based on readily
available standard parameters can support clinical
decision-making on performing angiography or other
diagnostic evaluations in these individual patients.
A limitation of our study is that certain low-risk
patients, who might ﬁt the inclusion criteria, were select-
ively not included in our study because they were not
referred to the clinic. This could compromise the results
because of veriﬁcation bias.19 Since our university hos-
pital also has an important secondary healthcare func-
tion, the effect of the bias is expected to be rather small,
but some patients might have visited other departments
(such as radiology) and not have been referred because
of a low-risk proﬁle. On the other hand, we noted a
wide spectrum of included patients and our study popu-
lation was somewhat more heterogeneous than the
development population. Apart from considering the
model reproducibility, transportability ‘across samples
from different but related source populations’ is import-
ant to consider.13 Other studies have also applied similar
models in another context, like taking the cut-off value
for stenosis at 70% and applying CT angiography (but
without presenting coefﬁcients)20 or focussing on
patients with valvular heart disease,21 and the results
barely differed. Another study was based on coronary
CT angiography to capture the disease status and
Table 2 Baseline characteristics of the study patients by CAD* status
No CAD
n=1381
Non-obstructive
n=1606
One-vessel
disease
n=997
Two-vessel
disease
n=475
Three-vessel
disease
n=429
Sex, male 45% 60% 73% 79% 79%
Age (years), ms 59 (11) 66 (10) 65 (10) 67 (10) 67 (11)
Chest pain 54% 58% 66% 70% 73%
Diabetes mellitus 9% 16% 17% 20% 25%
Hypertension 67% 79% 78% 84% 82%
Smoking status
Former 22% 25% 29% 28% 29%
Current 20% 19% 21% 22% 23%
HDL cholesterol (mg/dL), ms 60.9 (18.9) 57.0 (17.0) 54.0 (15.1) 52.0 (14.9) 52.2 (15.9)
LDL cholesterol (mg/dL), ms 127 (34) 126 (36) 131 (40) 130 (38) 135 (40)
Triglycerides (mg/dL), mi 115 (84; 160) 126 (90; 172) 126 (93; 180) 134 (99; 186) 140 (98; 184)
Fibrinogen (mg/dL), mi 341 (277; 408) 362 (296; 443) 368 (301; 455) 370 (304; 462) 384 (318; 481)
C reactive protein >1.00 mg/dL 10% 13% 18% 16% 19%
γ-glutamyltransferase (U/L), mi 29 (19; 50) 32 (20; 56) 33 (22; 53) 35 (22; 56) 34 (23; 57)
Uric acid (mg/dL), ms 5.87 (1.66) 6.39 (1.73) 6.42 (1.65) 6.58 (1.70) 6.53 (1.66)
*CAD cut-off at 70% stenosis, for the left main artery at 50%; the left anterior descending, proximal and distal left anterior descending arteries
add up to one vessel, the left main artery is counted as three vessels.
CAD, coronary artery disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; mi, median (IQR); ms, mean (SD).
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concluded that applying an invasive angiography-based
probability model led to poor risk estimates.22 External
validation research can highlight the amount of vari-
ation in performance to select patients for further diag-
nostic work-up.
The increase in performance by laboratory results
needs further validation, speciﬁcally whether this
improvement would also apply in a patient group more
similar to that of the development model. Since risk
factor evaluation and the considered laboratory para-
meters are already part of the routine patient evaluation,
the diagnostic work-up could easily be enhanced by
applying the presented model.
In the prediction of obstructive CAD diagnosis, the
presence of typical chest pain symptoms was originally a
very strong factor. In our cohort, it was much less pro-
nounced. Presented as ORs, it concerns the difference
between 7.4 and 1.7, respectively. Actually, Genders et al3
had classiﬁed the symptoms according to recommended
criteria, that is, substernal chest pain or discomfort, pro-
voked by exertion or emotional stress and relieved by
rest or nitroglycerine. The importance of chest pain cat-
egorisation has been questioned recently.23 In clinical
practice, chest pain or discomfort evaluation is com-
monly more subjective and may be strongly inﬂuenced
by sex and age with older women presenting with more
atypical symptoms.24 25 Accordingly, Genders et al3 devel-
oped their model in a group with more male patients
(70% vs 62% in our study). Although the symptom cri-
teria are also rather subjective in nature, they seem to
advance the diagnostic process whereas our routine-
based categorisation is simpler. The large difference in
coefﬁcients found may emphasise room for improve-
ment in evaluating chest pain in daily clinical practice.
Further research on this topic would help to unravel the
issues involved.
Figure 1 Calibration plots of the predicted probability against
the observed proportion of coronary artery disease (≥50%
stenosis) of the 4888 CARDIIGAN patients with 95%
confidence band for (A) the clinical model of Genders et al,3
(B) the re-estimated model and (C) the extended model;
below the main graph the frequency distribution of coronary
artery disease cases (upward) and without stenosis
(downward) is shown. CARDIIGAN, Coronary Artery disease
Risk Determination In Innsbruck by diaGnostic ANgiography.
Figure 2 Decision curve for two prediction models of
coronary artery disease (≥50% stenosis) of the 4888
CARDIIGAN patients. Note: the horizontal dotted line at net
benefit=0.00 assumes that no patients are subjected to
diagnostic work-up, the first descending dashed curve (cutting
the horizontal dotted line of net benefit=0.00 at a threshold
probability=0.44) is based on the assumption that all patients
undergo diagnostic work-up for stenosis, the next
long-dash-and-dot curve to the right displays the re-estimated
model, and the upper solid line the extended model.
CARDIIGAN, Coronary Artery disease Risk Determination In
Innsbruck by diaGnostic ANgiography.
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Besides a possible veriﬁcation bias, our study was
limited by the fact that some data were missing, not
uncommon for an observational study. Neglecting it by
applying a complete-case analysis would potentially have
led to less valid and less precise results, actually a waste
of resources.26 Therefore, multiple imputation model-
ling was used, a method that is appreciated for being
able to address the problem adequately. Furthermore,
the patient group studied here differed in many respects
from that of the original model. Compared with
Genders et al,3 there were less CAD cases (44% vs 60%)
and fewer men (62% vs 70%) in our CARDIIGAN
cohort, but the age distribution and mean body mass
index were similar, as well as the prevalence of diabetes
(15% vs 18%). Chest pain (61% vs 53%), hypertension
(76% vs 67%) and smoking (46% vs 36%) were more
prevalent in our study (table 1). This may compromise
to some extent the generalisability of our ﬁndings, even
though the inclusion of consecutive patients referred for
invasive evaluation of suspected CAD reﬂects daily prac-
tice. However, the development study was a consortium
of 18 hospitals from all parts of Europe and North
America, in which the wide range of settings did not
pose a problem.3 For example, in that multicentre study,
typical chest pain proportions varied from 1% to 64%,
male sex from 42% to 77%, diabetes from 6% to 40%
and smoking 19% to 63%, and mean age from 51 to
66 years. So the target population can be represented by
a diverse spectrum of characteristics and our cohort
adds some further insights. Another limitation here con-
cerns the time period since the inclusion of the patients,
since technologies have developed further and nowadays
more laboratory results are routinely available. However,
the effects of predictors may not have changed within a
decade and diagnostic CAD validation studies are still
scarce. Our study might be a stimulus to further elabor-
ate on this subject.
The European Society of Cardiology (ESC) guidelines
on the management of stable CAD recommend different
non-invasive tests, especially in patients with an inter-
mediate pretest probability, like CT-based CA, exercise
stress test or stress imaging testing.27 Patients with low
pretest probability should not be further evaluated and
those with a high probability ought to be directly
referred for invasive angiography. However, most of the
patients with suspected CAD in daily clinical practice are
within the wide range of intermediate risk, highlighting
the need for better performance of prediction models
before selecting one (or multiple) non-invasive modal-
ities or even referring to invasive CA. Besides different
patient characteristics, some of the differences in model
performance between the development patient group
and our cohort might stem from the patient recruitment
strategies used. In the study by Genders et al3 there was a
high percentage of CT angiography applied, indicating a
preselection of patients. In clinical practice, physicians
are faced by the whole range of pretest probabilities in
their patients including all non-invasive diagnostic
strategies. Our data comprise of such patients as they
were unselectively referred for invasive CA by different
kinds of medical doctors (general practitioners, general
internists, cardiologists, etc), with the limitation of no
information about exact frequencies, results and quality
of prior non-invasive tests.
However, we had the possibility to analyse a large
cohort with prospectively collected, good-quality data.
Also, several routine laboratory measurements were avail-
able, permitting assessment of their additive value for
obstructive CAD diagnostics.
Although a new extended model needs validation, one
can assess clinical usefulness of the current model.
Speciﬁcity increased 1.4% through application of the
extra predictors, while sensitivity improved 3.4%.
Therefore, the true-positive rate was raised indicating an
increase in affected patients being classiﬁed properly,
with at the same time an increase in potential number
of angiographies saved. We also found a wide range of
threshold probabilities in which a diagnostic prediction
model would be advantageous. So when deciding on an
angiography, differential rating of the procedure disad-
vantages will not easily tip the balance against applying a
model. In the future further evaluation of the optimal
decision threshold to classify patients is necessary, since
this allows assessing to what extent better decisions are
made with a model than without one or with a compari-
son between models.16 More elaborate research differen-
tiating obstructive CAD by its severity can surely be
helpful to aid the decision-making process. Also,
research should further be encouraged to advance
knowledge about effects of preinvasive selections on
patient management strategies (PCI, coronary artery
bypass grafting or optimal medical therapy alone),28 to
avoid unnecessary conventional CA.
In conclusion, this study externally validated a sug-
gested CAD prediction model which in its original form
might not automatically be transportable to other clin-
ical settings. Additional laboratory predictors and updat-
ing led to a model that can be useful to predict an
obstructive CAD diagnosis, next to a thorough clinical
evaluation; both are warranted as a pre-requisite for
better (ie, faster, less expensive, lower risk) diagnostic
strategies.
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